Study of RP-3500, Camonsertib, in Advanced Solid Tumors

Clinical trial NCT04497116 · COMPLETED

Trial details

NCT number: NCT04497116
Sponsor: Repare Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2020-07-22
Primary completion: 2025-06-13
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.